Home Finance Moderna Confirms FDA Delayed Covid-19 Vaccine in Adolescents to Review Myocarditis Risk

Moderna Confirms FDA Delayed Covid-19 Vaccine in Adolescents to Review Myocarditis Risk

22
0

Moderna Confirms FDA Delayed Covid-19 Vaccine in Adolescents to Review Myocarditis Risk


Moderna said more than 1.5 million adolescents have received its vaccine. A 16-year-old patient took part in a Moderna Covid-19 vaccine clinical trial.

Photo: Paul Hennessy/Zuma Press

Published at Sun, 31 Oct 2021 16:34:00 +0000

https://www.wsj.com/articles/moderna-confirms-fda-delayed-covid-19-vaccine-in-adolescents-to-review-myocarditis-risk-11635698082?mod=pls_whats_news_us_business_f

Previous articleVaccine Mandates Turn Into Religious Tests at GE, Disney, Others
Next articleNot Yet on Track: Climate Threat Demands More Ambitious Global Action